The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Moving gene therapies from preclinical studies to clinical and commercial manufacturing is complex Journey that requires significant financial investment — and it’s filled with risks and challenges.
Using Thermo Fisher Scientific's end-to-end manufacturing service, we deliver high-performance, scalable, AAV and lentiviral vectors to clinics. As a result of this service, you can deliver therapy to clinics while de-risking timelines and global regulatory filings without additional or surprising out-of-pocket costs.